Exciting things are happening at KeraLink and we're hiring! As the future Director of Development, you will have the opportunity to play an instrumental role in the prevention, early detection, and novel treatment of corneal injury, disease, and blindness. Learn more here: https://lnkd.in/eYG4J4B6
KeraLink International
Non-profit Organization Management
Baltimore, Maryland 3,230 followers
Working to eliminate corneal blindness globally
About us
KeraLink International is a 501(c)3 nonprofit organization with a mission focused on developing solutions to make treatment of corneal blindness affordable and accessible to all in need. Founded in 1962 as the Medical Eye Bank of Maryland, KeraLink’s mission has always been committed to restoring sight. KeraLink sold its U.S. eye-banking assets in 2019 to singularly focus on harnessing technological advancements and social venture financing strategies to make corneal blindness treatment more accessible and affordable in the developing world.
- Website
-
http://www.keralink.org
External link for KeraLink International
- Industry
- Non-profit Organization Management
- Company size
- 2-10 employees
- Headquarters
- Baltimore, Maryland
- Type
- Nonprofit
- Founded
- 1962
Locations
-
Primary
Get directions
P.O. Box 22575
Baltimore, Maryland 21203, US
Employees at KeraLink International
-
David Green
CEO of KeraLink International. Ashoka Fellow; MacArthur Awardee. High Impact Social Entrepreneur in Medical Device Development.
-
Noel Selegzi
Mission Driven Nonprofit Director
-
Michelle Bockman
Chief Executive Officer | Co-Founder | Enterprise Go-To-Market Leadership | Profit and Loss Growth Strategist | Advisor |Technologist
-
Sasipriya Karumanchi
Consultant (Eye care)
Updates
-
We “see change” and it’s an exciting time for KeraLink! Today we announced Michelle Bockman as our new President and CEO. Her extensive background in managing complex global projects and her passionate commitment to our cause are exactly what KLI needs to move forward. We also thank David Green as he has transitioned to a pivotal role as KLI’s Chief Technology and Investment Officer. Green, a visionary leader, will now focus on discovering, developing, deploying, and investing in new technologies for the prevention, early detection, and novel treatment of corneal conditions. Read more here: https://lnkd.in/e5ZSVYx7
-
Congratulations to our CEO, Dsvid Greene.
We're thrilled to announce the inauguration of the "David Green Centre of Sustainable Eye Care" at Dr. Shroff's Charity Eye Hospital, Delhi! 🏥 Join us in celebrating Mr. David Green's incredible journey with SCEH. His unwavering dedication to enhancing accessibility and sustainability in healthcare technology is truly commendable. David's collaboration with SCEH has been instrumental in initiatives that would prevent corneal blindness, enable early detection and leverage technology to reduce the healthcare cost making it more affordable for the community and sustainable for the hospital. At the heart of SCEH's collaboration with David Green is our commitment to provide affordable and accessible eye health care not just for those who can afford but also for low income patients. He has been helping SCEH improve processes, optimize resources and leverage technology to become self-sufficient, generating revenue to subsidize treatments for low-income individuals. Sustainable hospitals are the backbone of community health services, ensuring that no one is left behind. Through this collaboration, we're witnessing tangible improvements in eye healthcare for the community. #EyeHealth #Sustainability #CommunityCare
-
-
Give the Gift of Sight this #givingtuesday2023.
Donate - Keralink International
keralink.org
-
Today is World Sight Day! The World Health Organization reports that at least 2.2 billion people globally have a near or distant vision impairment. In at least 1 billion of these cases, the visual impairment could have been prevented or has yet to be addressed. Corneal blindness is a leading cause of visual impairment and blindness, but corneal injuries and conditions can be prevented. When detected early, they are often easily treated. The only cure for corneal blindness is a human tissue transplant, but new therapies are making it possible to prevent and reverse corneal blindness without donor tissue. No one should go blind from corneal disease. Delayed diagnosis or treatment, lack of access to corneal tissue, or trained surgeons are the main limiting factors to treating corneal blindness in LMICs. KeraLink is working to change the paradigm for addressing corneal blindness. We are investing in accelerating the process of discovering, developing, and deploying new technologies for the Prevention, Early detection, and Novel treatment of corneal injuries and disease. By partnering with other organizations globally and investing in innovative technologies, we seek to eliminate the need for human tissue for most penetrating keratoplasty procedures and simplify complex procedures so more surgeons can perform them throughout rural areas to populations who require them and increase corneal screenings. Our goal is to eliminate avoidable corneal blindness. #worldsightday #cornealblindness #visionscrenning #iapb
-
-
Read the first issue KeraLink International's free monthly newsletter, the Cornea Chronicle, today. Subscribe to receive the Cornea Chronicle every month via email.
Cornea Chronicle
https://keralink.org
-
Read the first issue KeraLink International's free monthly newsletter, the Cornea Chronicle, today. Subscribe to receive the Cornea Chronicle every month via email.
Cornea Chronicle
https://keralink.org